Use App
Trending
News
Earnings
Newsletters
Advertise
All
DIA
0.37%
SPY
0.05%
QQQ
0.17%
Trending
APLD
38.36%
AVT
0.53%
PATH
23.02%
LAES
38.69%
YDDL
394.31%
WULF
20.94%
ZEC
36.18%
LTC
11.66%
TTRX
27.08%
CCCX
37.03%
APLD
38.36%
AVT
0.53%
PATH
23.02%
LAES
38.69%
YDDL
394.31%
WULF
20.94%
ZEC
36.18%
LTC
11.66%
TTRX
27.08%
CCCX
37.03%
home
Symbol
NVST
NVST
Envista Holdings Corp
403
Loading...
Loading...
Feed
News
Sentiment
Earnings
Fundamentals
Info
News
all
press releases
Nyxoah Shares Rise on First U.S. Commercial Use of Genio System
NYXH's first U.S. commercial use of its Genio system signals strong physician demand and sets the stage for broad adoption in sleep apnea care.
Zacks
·
2d ago
Share to Feed
More News
ICCM Shares Rise as FDA Clears ProSense for Breast Cancer Treatment
IceCure Medical shares surge after FDA clears ProSense, marking the first minimally invasive breast cancer treatment for women aged 70 and above.
Zacks
·
4d ago
Here's Why Envista (NVST) is a Strong Value Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Zacks
·
11d ago
Bio-Techne Stock Climbs on Advances in Spatial Biology Solutions
TECH shares rise as advances in RNAscope and COMET spotlight new roles in lymphoid malignancy diagnostics.
Zacks
·
11d ago
HTFL Gains FDA Clearance & Cigna Coverage for Next Gen Plaque Analysis
Heartflow secures FDA clearance and Cigna coverage for its Next Gen Plaque Analysis, boosting accuracy and nationwide access.
Zacks
·
11d ago
NVST vs. ABT: Which Stock Is the Better Value Option?
NVST vs. ABT: Which Stock Is the Better Value Option?
Zacks
·
13d ago
GEHC Inks License Agreement With Lantheus for Prostate Imaging Agent
GE HealthCare strengthens its radiopharmaceutical portfolio by licensing Lantheus' PSMA PET imaging agent, PYLARIFY, for commercialization in Japan.
Zacks
·
14d ago
Growing Diagnostics Arm Supports ABT Stock, Macro Issues Ail
ABT gains momentum with strong FreeStyle Libre sales and Diagnostics growth but global macro headwinds weigh on performance.
Zacks
·
14d ago
TMDX Partners With Mercedes-Benz to Launch Organ Transport Network
TransMedics collaborates with Mercedes-Benz to launch Italy's first organ transport network, expanding its OCS model beyond the United States.
Zacks
·
14d ago
National Vision Gains 166.5% in a Year: What's Driving the Rally?
EYE's 166.5% stock surge in a year is fueled by transformation efforts, partnerships, and strong growth in its Owned & Host segment.
Zacks
·
15d ago
Latest NVST News
View
Advertisement
|
Remove ads.
Advertisement
|
Remove ads.
Advertisement
|
Remove ads.
Watchlist
Trending
News
Explore
Community
Profile